The U.S. Food and Drug Administration (FDA) has launched a new AI-powered safety monitoring system capable of processing millions of consumer complaints in real time, aiming to identify potential issues with beauty products before they gain widespread attention on social media platforms like TikTok.
As part of its Adverse Event Monitoring System (AEMS) initiative, which seeks to improve the monitoring of adverse events or reports of product issues, the agency has adopted ThinkTrends' agentic Document AI platform.
The FDA's new initiative is designed to identify safety concerns and detect clusters of problems with regulated products—including cosmetics, drugs, foods, and medical devices—faster, earlier, and more rigorously.
The new platform replaces fragmented reporting systems with a unified, real-time monitoring structure capable of processing 6 to 7 million adverse event reports annually. It aggregates consumer complaints, clinical reports, and manufacturer data.
Historically, cosmetic products have been under-monitored compared to other categories. With the new system, negative reactions such as irritation, burns, discoloration, or hair loss can be flagged instantly.
The agency intends for the system to expedite product recalls or warnings, shortening the timeline between consumer complaints and regulatory action.
For beauty manufacturers, this move signals further adoption of AI in the industry, making it critical for safety monitoring, ingredient risk prediction, and regulatory compliance.
Source: Read the original report | Published: May 07, 2026